Graphic

SCIENTIFIC
PUBLICATIONS

The scientific outcome in 2018 has consisted of 19 published articles:

  • 1. OXIDIZED ALBUMIN TRIGGERS A CYTOKINE STORM IN LEUKOCYTES THROUGH P38 MITOGEN-ACTIVATED PROTEIN KINASE: ROLE IN SYSTEMIC INFLAMMATION IN DECOMPENSATED.

    Alcaraz-Quiles J, Casulleras M, Oettl K, Titos E, Flores-Costa R, Hepatology. 2018 Nov; 68:1937-1952. doi: 10.1002/hep.30135. OR

  • 2. MULTIDRUG-RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND WITH ACLF ACROSS EUROPE.

    Fernandez J, Prado V, Trebicka J, Amoros A, Gustot T, J Hepatol. 2018 Nov 2. pii: S0168-8278(18)32511-X. doi: 10.1016/j.jhep.2018.10.027. OR

  • 3. LIVER TRANSPLANTATION IN PATIENTS WITH ACLF AND MULTIPLE ORGAN FAILURE: TIME FOR PRIORITY AFTER INITIAL STABILIZATION.

    Fernández J, Saliba F, J Hepatol. 2018 Sep 18. pii: S0168-8278(18)32372-9. doi: 10.1016/j.jhep.2018.09.002. ED

  • 4. ACUTE-ON-CHRONIC LIVER FAILURE VS. TRADITIONAL ACUTE DECOMPENSATION OF CIRRHOSIS.

    Gustot T, Moreau R, J Hepatol. 2018 Sep 6. pii: S0168-8278(18)32370-5. doi: 10.1016/j.jhep.2018.08.024. REV

  • 5. MIDODRINE&ALBUMIN FOR PREVENTING COMPLICATIONS INPATIENTS WITH CIRRHOSIS AWAITING LIVER TRANSPLANTATION.

    Solà E, Solé C, Simón-Talero M, Martín-Llahí M, Castellote J, J Hepatol. 2018 Dec; 69:1250-1259. doi: 10.1016/j.jhep.2018.08.006. OR

  • 6. THE PROGNOSTIC VALUE OF ACUTE-ON-CHRONIC LIVER FAILURE DURING THE COURSE OF SEVERE ALCOHOLIC HEPATITIS.

    ersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, J Hepatol. 2018 Aug; 69:318-324. doi: 10.1016/j.jhep.2018.02.022. Epub 2018 Mar 8. OR

  • 7. DYNAMIC PROGNOSTICATION IN CRITICALLY ILL CIRRHOTIC PATIENTS WITH MULTIORGAN FAILURE IN ICUS IN EUROPE AND NORTH AMERICA: A MULTICENTER ANALYSIS.

    Karvellas CJ, Garcia-Lopez E, Fernandez, Saliba F, Sy E, Crit Care Med. 2018 Aug 13. doi: 10.1097/CCM.0000000000003369. OR

  • 8. SYSTEMIC INFLAMMATION AND ACUTE-ON- CHRONIC LIVER FAILURE: TOO MUCH, NOT ENOUGH.

    Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J, Can J Gastroenterol Hepatol. 2018 Aug 1; 2018:1027152. doi: 10.1155/2018/1027152. eCollection 2018. REV

  • 9. ADVERSE EVENTS AND ACUTE CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSI UNDERGOING ENDOSCOPIC RETROGDRADE CHOLANGIO- PANCREATOGRAPHY: A MULTICENTER MAT.

    Leal C, Prado V, Colan J, Chavez-Rivera K, Sendino O, Am J Gastroenterol. 2019 Jan; 114:89-97. doi: 10.1038/s41395-018-0218. OR

  • 10. GUT-LIVER AXIS LINKS PORTAL HYPERTENSION TO ACUTE-ON-CHRONIC LIVER FAILURE.

    Trebicka J, Reiberges T, Laleman W., Visc Med, Aug;34:270-275. doi: 10.1159/000490262. REV

  • 11. THE USE OF HUMAN ALBUMIN IN PATIENTS WITH CIRRHOSIS: A EUROPEAN SURVEY.

    Caraceni P, Pavesi M, Baldassarre M, Bernardi M, Arroyo V, Expert Rev Gastroenterol Hepatol. 2018 Jun; 12:625-632. doi: 10.1080/17474124.2018.1460203. Epub 2018 Apr 4. OR

  • 12. COAGULATION FAILURE IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) AND DECOMPENSATED CIRRHOSIS: BEYOND INR.

    Blasi A, Calvo A, Prado V, Reverter E, Carlos Reverter J, Hepatology. 2018 May 23. doi: 10.1002/hep.30103. OR

  • 13. ACUTE-ON-CHRONIC LIVER FAILURE, HUMAN SERUM ALBUMIN, AND IMMUNE MODULATION: THE BEGINNING OF AN EXCITING ADVENTURE.

    Arroyo V, Clària J, Clin Gastroenterol Hepatol. 2018 May; 16:633-636. doi: 10.1016/j.cgh.2017.12.008. Epub 2017 Dec 12. ED

  • 14. ACUTE-ON-CHRONIC LIVER FAILURE: GETTING READY FOR PRIME TIME?

    Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Hepatology. 2018 Apr 24. doi: 10.1002/hep.30056. OR

  • 15. THE SOLUBLE GUANYLATE CYCLASE STIMULATOR IW-1973 PREVENTS INFLAMMATION AND FIBROSIS IN EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS.

    Flores-Costa R, Alcaraz-Quiles J, Titos E, López-Vicario C, Casulleras M, Br J Pharmacol. 2018 Mar; 175:953-967. doi: 10.1111/bph.14137. OR

  • 16. CELL DEATH MARKERS IN PATIENTS WITH CIRRHOSIS AND ACUTE DECOMPENSATION.

    Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Hepatology. 2018 Mar; 67:989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24. OR

  • 17. FRONTLINE SCIENCE: SPECIALIZED PRORESOLVING LIPID MEDIATORS INHIBIT THE PRIMING AND ACTIVATION OF THE MACROPHAGE NLRP3 INFLAMMASOME.

    Lopategi A, Flores-Costa R, Rius B, López-Vicario C, Alcaraz-Quiles J, J Leukoc Biol. 2018 Mar 30. doi: 10.1002/JLB.3HI0517-206RR. OR

  • 18. ASSOCIATION BETWEEN GRADE OF ACUTE ON CHRONIC LIVER FAILURE AND RESPONSE TO TERLIPRESSIN AND ALBUMIN IN PATIENTS WITH HEPATORENAL SYNDROME.

    Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Clin Gastroenterol Hepatol. 2018 Jan 31. pii: S1542-3565(18)30105-8. doi: 10.1016/j.cgh.2018.01.035. OR

  • 19. PREVALENCE AND SHORT-TERM MORTALITY OF ACUTE-ON-CHRONIC LIVER FAILURE: A NATIONAL COHORT STUDY FROM THE USA.

    Hernaez R, Kramer J, Liu Y, Tansel A, Natarajan Y, Hussain K, Gines P, Sola E, Moreau R, Gerbes A, Kanwal F, El-Serag H, J Hepatol. 2018 Dec 25. pii: S0168-8278(18)32637-0. doi:10.1016/ j.jhep.2018.12.018. [Epub ahead of print]. OR

  • 1. OXIDIZED ALBUMIN TRIGGERS A CYTOKINE STORM IN LEUKOCYTES THROUGH P38 MITOGEN-ACTIVATED PROTEIN KINASE: ROLE IN SYSTEMIC INFLAMMATION IN DECOMPENSATED.

    Alcaraz-Quiles J, Casulleras M, Oettl K, Titos E, Flores-Costa R, Hepatology. 2018 Nov; 68:1937-1952. doi: 10.1002/hep.30135.

  • 2. MULTIDRUG-RESISTANT BACTERIAL INFECTIONS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS AND WITH ACLF ACROSS EUROPE.

    Fernandez J, Prado V, Trebicka J, Amoros A, Gustot T, J Hepatol. 2018 Nov 2. pii: S0168-8278(18)32511-X. doi: 10.1016/j.jhep.2018.10.027.

  • 3. MIDODRINE&ALBUMIN FOR PREVENTING COMPLICATIONS INPATIENTS WITH CIRRHOSIS AWAITING LIVER TRANSPLANTATION.

    Solà E, Solé C, Simón-Talero M, Martín-Llahí M, Castellote J, J Hepatol. 2018 Dec; 69:1250-1259. doi: 10.1016/j.jhep.2018.08.006.

  • 4. THE PROGNOSTIC VALUE OF ACUTE-ON-CHRONIC LIVER FAILURE DURING THE COURSE OF SEVERE ALCOHOLIC HEPATITIS.

    ersté T, Cornillie A, Njimi H, Pavesi M, Arroyo V, J Hepatol. 2018 Aug; 69:318-324. doi: 10.1016/j.jhep.2018.02.022. Epub 2018 Mar 8.

  • 5. DYNAMIC PROGNOSTICATION IN CRITICALLY ILL CIRRHOTIC PATIENTS WITH MULTIORGAN FAILURE IN ICUS IN EUROPE AND NORTH AMERICA: A MULTICENTER ANALYSIS.

    Karvellas CJ, Garcia-Lopez E, Fernandez, Saliba F, Sy E, Crit Care Med. 2018 Aug 13. doi: 10.1097/CCM.0000000000003369.

  • 6. ADVERSE EVENTS AND ACUTE CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSI UNDERGOING ENDOSCOPIC RETROGDRADE CHOLANGIO- PANCREATOGRAPHY: A MULTICENTER MAT.

    Leal C, Prado V, Colan J, Chavez-Rivera K, Sendino O, Am J Gastroenterol. 2019 Jan; 114:89-97. doi: 10.1038/s41395-018-0218.

  • 7. THE USE OF HUMAN ALBUMIN IN PATIENTS WITH CIRRHOSIS: A EUROPEAN SURVEY.

    Caraceni P, Pavesi M, Baldassarre M, Bernardi M, Arroyo V, Expert Rev Gastroenterol Hepatol. 2018 Jun; 12:625-632. doi: 10.1080/17474124.2018.1460203. Epub 2018 Apr 4.

  • 8. COAGULATION FAILURE IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) AND DECOMPENSATED CIRRHOSIS: BEYOND INR.

    Blasi A, Calvo A, Prado V, Reverter E, Carlos Reverter J, Hepatology. 2018 May 23. doi: 10.1002/hep.30103.

  • 9. ACUTE-ON-CHRONIC LIVER FAILURE: GETTING READY FOR PRIME TIME?

    Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Hepatology. 2018 Apr 24. doi: 10.1002/hep.30056.

  • 10. THE SOLUBLE GUANYLATE CYCLASE STIMULATOR IW-1973 PREVENTS INFLAMMATION AND FIBROSIS IN EXPERIMENTAL NON-ALCOHOLIC STEATOHEPATITIS.

    Flores-Costa R, Alcaraz-Quiles J, Titos E, López-Vicario C, Casulleras M, Br J Pharmacol. 2018 Mar;

  • 11. CELL DEATH MARKERS IN PATIENTS WITH CIRRHOSIS AND ACUTE DECOMPENSATION.

    Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Hepatology. 2018 Mar; 67:989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24.

  • 12. FRONTLINE SCIENCE: SPECIALIZED PRORESOLVING LIPID MEDIATORS INHIBIT THE PRIMING AND ACTIVATION OF THE MACROPHAGE NLRP3 INFLAMMASOME.

    Lopategi A, Flores-Costa R, Rius B, López-Vicario C, Alcaraz-Quiles J, J Leukoc Biol. 2018 Mar 30. doi: 10.1002/JLB.3HI0517-206RR.

  • 13. ASSOCIATION BETWEEN GRADE OF ACUTE ON CHRONIC LIVER FAILURE AND RESPONSE TO TERLIPRESSIN AND ALBUMIN IN PATIENTS WITH HEPATORENAL SYNDROME.

    Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Clin Gastroenterol Hepatol. 2018 Jan 31. pii: S1542-3565(18)30105-8. doi: 10.1016/j.cgh.2018.01.035.

  • 14. PREVALENCE AND SHORT-TERM MORTALITY OF ACUTE-ON-CHRONIC LIVER FAILURE: A NATIONAL COHORT STUDY FROM THE USA.

    Hernaez R, Kramer J, Liu Y, Tansel A, Natarajan Y, Hussain K, Gines P, Sola E, Moreau R, Gerbes A, Kanwal F, El-Serag H, J Hepatol. 2018 Dec 25. pii: S0168-8278(18)32637-0. doi:10.1016/ j.jhep.2018.12.018. [Epub ahead of print].

  • 1. ACUTE-ON-CHRONIC LIVER FAILURE VS. TRADITIONAL ACUTE DECOMPENSATION OF CIRRHOSIS.

    Gustot T, Moreau R, J Hepatol. 2018 Sep 6. pii: S0168-8278(18)32370-5. doi: 10.1016/j.jhep.2018.08.024.

  • 2. SYSTEMIC INFLAMMATION AND ACUTE-ON- CHRONIC LIVER FAILURE: TOO MUCH, NOT ENOUGH.

    Laleman W, Claria J, Van der Merwe S, Moreau R, Trebicka J, Can J Gastroenterol Hepatol. 2018 Aug 1; 2018:1027152. doi: 10.1155/2018/1027152. eCollection 2018.

  • 3. GUT-LIVER AXIS LINKS PORTAL HYPERTENSION TO ACUTE-ON-CHRONIC LIVER FAILURE.

    Trebicka J, Reiberges T, Laleman W., Visc Med, Aug;34:270-275. doi: 10.1159/000490262.

 
  • 1. . LIVER TRANSPLANTATION IN PATIENTS WITH ACLF AND MULTIPLE ORGAN FAILURE: TIME FOR PRIORITY AFTER INITIAL STABILIZATION.

    Fernández J, Saliba F, J Hepatol. 2018 Sep 18. pii: S0168-8278(18)32372-9. doi: 10.1016/j.jhep.2018.09.002.

  • 2. ACUTE-ON-CHRONIC LIVER FAILURE, HUMAN SERUM ALBUMIN, AND IMMUNE MODULATION: THE BEGINNING OF AN EXCITING ADVENTURE.

    Arroyo V, Clària J, Clin Gastroenterol Hepatol. 2018 May; 16:633-636. doi: 10.1016/j.cgh.2017.12.008. Epub 2017 Dec 12